These benefits, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like habits in mice,two aid the strategy of targeting ACKR3 as a novel approach to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Issues. Gene expression analysis unveiled that ACKR3 https://elliotta158rmd0.cosmicwiki.com/user